Zebrafish Screen for Drug-Induced Long QT & Cyp3A

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$100,000.00
Award Year:
2005
Program:
SBIR
Phase:
Phase I
Contract:
1R43HL082048-01
Award Id:
75760
Agency Tracking Number:
HL082048
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
Zygogen, Llc, 24 Peachtree Center Ave, Kell Hall 520, Atlanta, GA, 30303
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
TIMOTHY BARANOWSKI
(404) 523-7309
TIM@ZYGOGEN.COM
Business Contact:
(404) 523-7309
nina@zygogen.com
Research Institution:
n/a
Abstract
DESCRIPTION (provided by applicant): Many therapeutic drugs have been withdrawn from market because they were found to cause Torsade de Pointes (TdP), a rare cardiac arrhythmia that often results in death. Because TdP is associated with prolongation of the QT interval (long QT) on electrocardiograms, new drugs must now be tested for their effect on long QT before they can be approved. Thus, assays to predict QT prolongation have become increasingly important to the pharmaceutical industry. Current assays are performed in vitro or in cell culture and are limited by biological simplicity, low throughput, a high rate of false positives, and an inability to detect drug-drug interactions. In vivo assays in mammals are expensive and time-consuming. A great need exists for an in vivo assay that can rapidly and accurately predict QT prolongation in humans. A recent study showed that compounds that cause long QT in humans cause bradycardia in live zebrafish embryos. In Phase I, we propose to refine this assay to more accurately predict which compounds will cause long QT in humans, develop algorithms for automation of the assay to increase throughput, and to further develop the assay for detecting drug-drug interactions caused by inhibition of Cytochrome P450 3A, the enzyme responsible for most known drug-drug interactions in humans. In phase II, full automation of the assay will be implemented and the assay will eventually be provided as a commercial service to pharmaceutical companies.

* information listed above is at the time of submission.

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government